How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

4,365 results for

adhd Cognitive behavioural therapy

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Managing Anxiety in Children With ADHD Using Cognitive-Behavioral Therapy: A Pilot Randomized Controlled Trial. (Abstract)

Managing Anxiety in Children With ADHD Using Cognitive-Behavioral Therapy: A Pilot Randomized Controlled Trial. This pilot randomized controlled trial examined the acceptability and feasibility of a cognitive-behavioral therapy (CBT) intervention for children with ADHD and anxiety, and provided preliminary information on child and family outcomes.Children with ADHD and anxiety (8-12 years) were randomized to receive an adapted version of the Cool Kids CBT program or usual clinical care. Key (...) outcomes included feasibility and acceptability of the intervention (participant enrollment, drop-out, intervention session attendance), remission of anxiety assessed via diagnostic interview, ADHD symptom severity, quality of life (QoL), and parent mental health.Twelve children participated (67% uptake). Most families attended all 10 intervention sessions, with no drop-outs. Intervention participants had marked improvements in both child and family well-being by parent and teacher report, including

2015 Journal of attention disorders Controlled trial quality: uncertain

162. Effectiveness of mental health electronic medical records

level Hierarchy of Evidence based on a combination of recommendations from the National Health and Medical Research Council (NHMRC), the Oxford Centre for Evidence-based Medicine Levels of Evidence and a publication by Melynyk and Fineout-Overholt (2011). Most of the papers included in our review were graded as low quality, with only two randomised controlled trials identified. Key findings A total of 14 primary research studies focussed on EMRs in mental health settings and eight literature reviews (...) , workflows, and the needs of clinicians at the frontlines of clinical care, while avoiding duplication of information handling and ensuring that the EMRs solutions minimise disruption to rapport-building between patient and clinician during consultations. This will require an investment in formative evaluation, consultation and engagement through co-design. EFFECTIVENESS OF MENTAL HEALTH ELECTRONIC MEDICAL RECORDS | SAX INSTITUTE 9 Background Purpose This Evidence Check review was commissioned by the Sax

2020 Sax Institute Evidence Check

163. Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy

Drug: Sugar Pill In-active sugar pill randomly assigned at baseline visit Outcome Measures Go to Primary Outcome Measures : Efficacy outcome as change from baseline in ADHDRS total score [ Time Frame: At 4 weeks ] SICI as a marker of ADHD Behaviors [ Time Frame: Baseline visit ] To evaluate pTMS-evoked Short Interval Cortical Inhibition (SICI) as a marker of the hyperactive-impulsive dimension in Attention Deficit Hyperactivity Disorder Cognitive Correlates of SICI Change [ Time Frame: 2 hours (...) " or react. The investigators also want to find if brain cell "firing" can tell us how severe of symptoms a child has from ADHD. Finally, the investigators want to see if giving an ADHD medication called atomoxetine can make the ADHD symptoms in a child better and if the improvement shows a change in brain "firing". Condition or disease Intervention/treatment Phase Attention Deficit Disorder With Hyperactivity Drug: Atomoxetine Drug: Sugar Pill Phase 3 Detailed Description: This study will evaluate Short

2011 Clinical Trials

164. Development of a Multi-faceted Cognitive Training Program for Children With Attention Deficit Hyperactivity Disorder (ADHD)

information Responsible Party: Children's Hospital Medical Center, Cincinnati ClinicalTrials.gov Identifier: Other Study ID Numbers: First Posted: May 12, 2011 Results First Posted: August 1, 2017 Last Update Posted: August 1, 2017 Last Verified: June 2017 Keywords provided by Children's Hospital Medical Center, Cincinnati: ADHD cognitive training Additional relevant MeSH terms: Layout table for MeSH terms Attention Deficit Disorder with Hyperactivity Hyperkinesis Attention Deficit and Disruptive Behavior (...) Development of a Multi-faceted Cognitive Training Program for Children With Attention Deficit Hyperactivity Disorder (ADHD) Development of a Multi-faceted Cognitive Training Program for Children With Attention Deficit Hyperactivity Disorder (ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached

2011 Clinical Trials

165. Cognitive functioning and treatment outcomes in a randomized controlled trial of internet-delivered drug and alcohol treatment. Full Text available with Trip Pro

Cognitive functioning and treatment outcomes in a randomized controlled trial of internet-delivered drug and alcohol treatment. Substance use disorders are associated with lower cognitive functioning, and this impairment is associated with poorer outcomes. The Therapeutic Education System (TES) is an internet-based psychosocial intervention for substance use disorders that may provide enhanced treatment for individuals with cognitive deficits. This secondary analysis investigates (...) the association between cognitive functioning and treatment outcomes in a large (N = 507) randomized controlled effectiveness trial of TES compared to treatment-as-usual conducted within outpatient programs in the National Drug Abuse Treatment Clinical Trials Network.All participants completed a computer-based cognitive assessment (Microcog™ short version) at baseline. Scores on subtests of attention, reasoning, and spatial perception were tested as moderators of the treatment effect on abstinence

2018 The American Journal on Addictions Controlled trial quality: uncertain

166. Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder. Full Text available with Trip Pro

Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder. To assess the effect of Osmotic-Release Oral System (OROS) methylphenidate (MPH) on a variety of measures evaluating academic performance, cognition, and social behavior in children with attention-deficit/hyperactivity disorder (ADHD).This double-blind, randomized, placebo-controlled, crossover laboratory school study enrolled 78 children aged 9-12 years (...) performance on a variety of academic tasks in school-aged children compared to placebo. Adverse effects reported were consistent with prior studies. CLINICAL TRIAL REGISTRY INFORMATION: Double-Blind, Randomized, Placebo-Controlled, Crossover Study Evaluating the Academic, Behavioral and Cognitive Effects of Concerta on Older Children with ADHD, URL: http://clinicaltrials.gov/ct2/show/NCT00799409, unique identifier: NCT00799409.

2011 Journal of Child and Adolescent Psychopharmacology Controlled trial quality: predicted high

167. Effects of OROS methylphenidate on academic, behavioral, and cognitive tasks in children 9 to 12 years of age with attention-deficit/hyperactivity disorder. (Abstract)

Effects of OROS methylphenidate on academic, behavioral, and cognitive tasks in children 9 to 12 years of age with attention-deficit/hyperactivity disorder. To assess effects of OROS methylphenidate on cognitive and academic tasks in 9 to 12 year olds with attention-deficit/hyperactivity disorder (ADHD).A double-blind, within-subject, crossover design was used to compare OROS methylphenidate with placebo in a laboratory classroom setting on several cognitive and academic tasks for 68 children (...) who met randomization criteria.Performance on the following measures was significantly better when children received individually optimized OROS methylphenidate than placebo: math fluency and accuracy measured by the Permanent Product Math Test, ADHD symptoms observed in the laboratory setting, computerized indices of attention and impulsivity as measured by the Test of Variables of Attention (TOVA), and visual-spatial working memory (Finger Windows Backwards). Study medication was well tolerated

2011 Clinical pediatrics Controlled trial quality: uncertain

168. Drug misuse prevention: targeted interventions

, including illegal drugs, 'legal highs' and prescription-only medicines. It aims to prevent or delay harmful use of drugs in children, young people and adults who are most likely to start using drugs or who are already experimenting or using drugs occasionally. This guideline does not cover broader activities, both population-level (universal) and targeted, that aim to build people's skills, resilience and ability to make positive decisions about their health and which address the wider determinants (...) decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off-label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding. 1.1 Delivering drug misuse prevention activities as part of existing services 1.1.1 Deliver drug misuse prevention activities for people in groups at risk through a range of existing statutory, voluntary

2017 National Institute for Health and Clinical Excellence - Clinical Guidelines

169. A Newly Designed Mobile-Based Computerized Cognitive Addiction Therapy App for the Improvement of Cognition Impairments and Risk Decision Making in Methamphetamine Use Disorder: Randomized Controlled Trial Full Text available with Trip Pro

in China.The main aim of this study was to test whether 4 weeks of a newly designed computerized cognitive addiction therapy (CCAT) app can improve cognitive impairments, eliminate drug-related attention bias, and attenuate risk decision-making behaviors in participants with MUD.Forty MUD participants were assigned randomly to either the CCAT group (n=20), who received 4 weeks of CCAT plus regular detoxification treatment as usual, or the control group (n=20), who only received the regular detoxification (...) A Newly Designed Mobile-Based Computerized Cognitive Addiction Therapy App for the Improvement of Cognition Impairments and Risk Decision Making in Methamphetamine Use Disorder: Randomized Controlled Trial Cognitive rehabilitation therapy has been found to improve cognitive deficits and impulse control problems in methamphetamine use disorder (MUD). However, there is limited research regarding this therapy's feasibility when using mobile-based health technologies in supporting recovery from MUD

2018 JMIR mHealth and uHealth Controlled trial quality: uncertain

170. Feasibility of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Adult Attention Deficit Disorder (ADD).

table for additonal information Responsible Party: Tel-Aviv Sourasky Medical Center ClinicalTrials.gov Identifier: Other Study ID Numbers: 0214-14 First Posted: August 1, 2014 Last Update Posted: March 8, 2018 Last Verified: March 2018 Additional relevant MeSH terms: Layout table for MeSH terms Attention Deficit Disorder with Hyperactivity Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders (...) provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 18 Years to 65 Years (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: Yes Criteria Inclusion Criteria: Patients between the ages of 18-65(male and female) Diagnosed as suffering from Attention-Deficit Hyperactivity Disorder according to the DSM IV Patients taking medication for ADHD will give their consent to stop those medication 48 before entering the study

2014 Clinical Trials

171. Cognitive Behavioral Therapy

Cognitive Behavioral Therapy Aka: Cognitive Behavioral Therapy II. Definition Time-limited, patient goal-oriented psychotherapy Replaces problematic thinking and behaviors with more adaptive patterns Challenges maladaptive beliefs, plans pleasurable activities, and extends exposure to unpleasant situations Monitors progress via symptom measures III. Indications Conditions for which CBT is as effective or more effective than medications ( ) Other conditions for which CBT is an effective adjunct Attention (...) -Deficit Hyperactivity Disorder ( ) s s s IV. Technique Time limited schedule One session per week (60-90 minutes each) Total course: 8 to 12 weeks Monitoring of progress Collect symptom measures frequently Goal-oriented treatment Patient directs goals and actively participates in their treatment Focus on changing maladaptive thoughts or behaviors Patient has weekly homework assignments Therapy Strategies Identify and challenge maladaptive thoughts and behaviors Schedule pleasant activities Extended

2018 FP Notebook

172. Preventing and Managing Infectious Diseases Among People who Inject Drugs in Ontario

>> Insight >> Action infection. While exact numbers of non-medical prescription-opioid users (i.e., those using prescribed opioids without a prescription) remain largely unknown, a recent cohort study from Montreal found users of prescription opioids displayed a higher number of infections than those using other drugs.(7) The cohort study found prescription-opioid users had greater numbers of high-risk behaviours such as syringe sharing, frequency of injection and injection in public spaces than other (...) who inject drugs o This element could include efforts to prevent or help people to stop injecting drugs, efforts to reduce the risk of infection (e.g., needle-exchange programs, safe consumption/injection sites, and opioid analgesic therapy) and enhancing education efforts for people who inject drugs (e.g., to minimize risk of infectious diseases, identify early symptoms of infectious diseases, and know where to seek treatment when needed). o Generally, the evidence for this element supported

2019 McMaster Health Forum

173. Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD

IPD: No Keywords provided by Saeed Azami, Allameh Tabatabai University: ADHD Cognitive-motor rehabilitation Active Control Group Stimulant Medication Additional relevant MeSH terms: Layout table for MeSH terms Attention Deficit Disorder with Hyperactivity Hyperkinesis Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms Central Nervous System Stimulants Methylphenidate (...) , and an active control on the executive functioning, learning, and behavioral symptoms of children with ADHD. Condition or disease Intervention/treatment Phase Attention Deficit Hyperactivity Disorder Other: Cognitive-Motor Rehabilitation Drug: Ritalin Other: Active Control Not Applicable Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 48 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single (Outcomes

2016 Clinical Trials

174. Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects

Disorder (ADHD) Detailed Description: Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in children, affecting approximately 5% children in Europe. Methylphenidate (MPH, trade name ritalin) is the most-commonly prescribed medication for ADHD children; it is also increasingly used in ADHD adults. In 2007, the European Commission requested a referral to the Committee for Medicinal Products for Human Use (CHMP) under Article 31 of Directive 2001/83/EC (...) Attention Deficit Disorder Additional relevant MeSH terms: Layout table for MeSH terms Disease Attention Deficit Disorder with Hyperactivity Hyperkinesis Pathologic Processes Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms Methylphenidate Central Nervous System Stimulants Physiological Effects of Drugs Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Membrane

2011 Clinical Trials

175. Does sensorimotor upper limb therapy post stroke alter behavior and brain connectivity differently compared to motor therapy? Protocol of a phase II randomized controlled trial Full Text available with Trip Pro

Does sensorimotor upper limb therapy post stroke alter behavior and brain connectivity differently compared to motor therapy? Protocol of a phase II randomized controlled trial The role of somatosensory feedback in motor performance has been warranted in the literature. Although sensorimotor deficits are common after stroke, current rehabilitation approaches primarily focus on restoring upper limb motor ability. Evidence for integrative sensorimotor rehabilitation approaches is scarce (...) measures will consist of somatosensory, motor and cognitive assessments, and a standardized resting-state functional magnetic resonance imaging protocol.The integration of sensory and motor rehabilitation into one therapy model might provide the added value of this therapy to improve sensorimotor performance post stroke. Insight in the behavioral and brain connectivity changes post therapy will lead to a better understanding of working mechanisms of therapy and will provide new knowledge for patient

2018 Trials

176. Effectiveness of alcohol and other drug interventions in at-risk Aboriginal youth

practice evidence (level 3) 27 Table 4: Studies with emerging practice evidence (level 4) 36 Table 5: Summary of grey literature AOD intervention evaluations targeting at risk Aboriginal youth 42 6 EFFECTIVENESS OF ALCOHOL AND OTHER DRUG INTERVENTIONS IN AT RISK ABORIGINAL YOUTH | SAX INSTITUTE Glossary of terms ACCHS Aboriginal Community Controlled Health Services AI American Indian AOD Alcohol and Other Drugs CBPR Community Based Participatory Research CBT Cognitive Behaviour Therapy CRA Community (...) of interventions (published 2005–2009) delivered outside educational settings, designed for young people (aged 11-25) with existing alcohol use problems. Nine intervention studies were included: nine counselling-based interventions and one medically-based intervention. The authors reported that none of the included intervention studies had consistently strong methodology. The most promising approaches to reduce alcohol-related harm are cognitive-behavioural therapy (CBT), family therapy and community

2018 Sax Institute Evidence Check

177. Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults

Intervention/treatment Phase Attention Deficit Hyperactivity Disorder (ADHD) Substance Use Disorder (SUD) Drug: Bupropion SR Not Applicable Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 32 participants Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: Efficacy Of Bupropion SR For Attention Deficit Hyperactivity Disorder (ADHD) In Adults With Recent Past or Current (...) Substance Use Disorders Study Start Date : May 1999 Actual Primary Completion Date : July 2001 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Bupropion Drug: Bupropion SR 100mg capsules Initial dosing 100mgSR every morning, to be titrated to 200mgSR twice daily maximum Other Name: Wellbutrin Outcome Measures Go to Primary Outcome Measures : Attention Deficit Hyperactivity Disorder Rating

2011 Clinical Trials

178. Attention-Deficit/Hyperactivity Disorder (ADHD) Brain Activity Changes to Psychostimulants

Additional relevant MeSH terms: Layout table for MeSH terms Attention Deficit Disorder with Hyperactivity Hyperkinesis Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms (...) Attention-Deficit/Hyperactivity Disorder (ADHD) Brain Activity Changes to Psychostimulants Attention-Deficit/Hyperactivity Disorder (ADHD) Brain Activity Changes to Psychostimulants - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more

2011 Clinical Trials

179. Non-pharmacological Interventions for Preschoolers With Attention Deficit Hyperactivity Disorder (ADHD)

Posted : June 4, 2014 Sponsor: Queens College, The City University of New York Information provided by (Responsible Party): Jeffrey Halperin, Queens College, The City University of New York Study Details Study Description Go to Brief Summary: This study is designed to evaluate two potential treatments for children with Attention-deficit/Hyperactivity Disorder (ADHD) that do not involve the use of medication. Our goal is to develop new interventions for preschoolers with ADHD that will result (...) with Hyperactivity Hyperkinesis Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms

2011 Clinical Trials

180. Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale and Epilepsy

): Hospices Civils de Lyon Study Details Study Description Go to Brief Summary: The cognitive and psychiatric comorbidities are crucial endpoints in epileptic patients. Among these comorbidities, the Attention-Deficit Hyperactivity Disorder (ADHD) accounts for one of the most important in terms of frequency and psychosocial and educational consequences. In these conditions, our study was designed to estimate the sensitivity to changes of the different sub-scores of the ADHD rating Scale IV (ADHD RS IV (...) Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale and Epilepsy Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale and Epilepsy - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Attention

2011 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>